Back to mobile site

Form SCHEDULE 13D RXO, Inc. Filed by: MFN Partners, LP

October 5, 2026 6:43 PM EDT





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
The securities represented in rows 8, 10 and 11 are comprised of (i) 4,577,327 shares of Common Stock issuable upon exercise of warrants with an exercise price of $0.01 which are only exercisable to the extent that following such exercise, the Reporting Persons' beneficial ownership of the Issuer, together with any attribution parties, does not exceed 19.9% ("Warrants"), and (ii) 28,109,942 shares of Common Stock. The number of shares of Common Stock outstanding for purposes of the percentage calculation in row 13 based on 164,926,128 shares of Common Stock outstanding as of August 4, 2026, as reported in the Issuer's quarterly report on Form 10-Q filed with the Securities and Exchange Commission on August 6, 2026, and gives effect to the exercise of 4,577,327 Warrants.


SCHEDULE 13D




Comment for Type of Reporting Person:
The securities represented in rows 8, 10 and 11 are comprised of (i) 4,577,327 shares of Common Stock issuable upon exercise of Warrants, and (ii) 28,109,942 shares of Common Stock. The number of shares of Common Stock outstanding for purposes of the percentage calculation in row 13 based on 164,926,128 shares of Common Stock outstanding as of August 4, 2026, as reported in the Issuer's quarterly report on Form 10-Q filed with the Securities and Exchange Commission on August 6, 2026, and gives effect to the exercise of 4,577,327 Warrants.


SCHEDULE 13D




Comment for Type of Reporting Person:
The securities represented in rows 8, 10 and 11 are comprised of (i) 4,577,327 shares of Common Stock issuable upon exercise of Warrants, and (ii) 28,109,942 shares of Common Stock. The number of shares of Common Stock outstanding for purposes of the percentage calculation in row 13 based on 164,926,128 shares of Common Stock outstanding as of August 4, 2026, as reported in the Issuer's quarterly report on Form 10-Q filed with the Securities and Exchange Commission on August 6, 2026, and gives effect to the exercise of 4,577,327 Warrants.


SCHEDULE 13D




Comment for Type of Reporting Person:
The securities represented in rows 8, 10 and 11 are comprised of (i) 4,577,327 shares of Common Stock issuable upon exercise of Warrants, and (ii) 28,109,942 shares of Common Stock. The number of shares of Common Stock outstanding for purposes of the percentage calculation in row 13 based on 164,926,128 shares of Common Stock outstanding as of August 4, 2026, as reported in the Issuer's quarterly report on Form 10-Q filed with the Securities and Exchange Commission on August 6, 2026, and gives effect to the exercise of 4,577,327 Warrants.


SCHEDULE 13D




Comment for Type of Reporting Person:
The securities represented in rows 8, 10 and 11 are comprised of (i) 4,577,327 shares of Common Stock issuable upon exercise of Warrants, and (ii) 28,109,942 shares of Common Stock. The number of shares of Common Stock outstanding for purposes of the percentage calculation in row 13 based on 164,926,128 shares of Common Stock outstanding as of August 4, 2026, as reported in the Issuer's quarterly report on Form 10-Q filed with the Securities and Exchange Commission on August 6, 2026, and gives effect to the exercise of 4,577,327 Warrants.


SCHEDULE 13D




Comment for Type of Reporting Person:
The securities represented in rows 8, 10 and 11 are comprised of (i) 4,577,327 shares of Common Stock issuable upon exercise of Warrants, and (ii) 28,109,942 shares of Common Stock. The number of shares of Common Stock outstanding for purposes of the percentage calculation in row 13 based on 164,926,128 shares of Common Stock outstanding as of August 4, 2026, as reported in the Issuer's quarterly report on Form 10-Q filed with the Securities and Exchange Commission on August 6, 2026, and gives effect to the exercise of 4,577,327 Warrants.


SCHEDULE 13D


 
MFN Partners, LP
 
Signature:/s/ Jonathan Reisman
Name/Title:Jonathan Reisman, Authorized Person
Date:10/05/2026
 
MFN Partners GP, LLC
 
Signature:/s/ Jonathan Reisman
Name/Title:Jonathan Reisman, Authorized Person
Date:10/05/2026
 
MFN Partners Management, LP
 
Signature:/s/ Jonathan Reisman
Name/Title:Jonathan Reisman, Authorized Person
Date:10/05/2026
 
MFN Partners Management, LLC
 
Signature:/s/ Jonathan Reisman
Name/Title:Jonathan Reisman, Authorized Person
Date:10/05/2026
 
Michael F. DeMichele
 
Signature:/s/ Michael F. DeMichele
Name/Title:Michael F. DeMichele, individually
Date:10/05/2026
 
Farhad Nanji
 
Signature:/s/ Farhad Nanji
Name/Title:Farhad Nanji, individually
Date:10/05/2026

ATTACHMENTS / EXHIBITS

EX-99.1



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings

Related Entities

13D